Glucosum

Glucosum is an intravenous solution whose active ingredient is glucose. It is supplied in a sterile liquid form intended for parenteral administration. The product is manufactured for the European market and is used to deliver a rapid source of carbohydrate energy directly into the bloodstream. Glucosum provides calibrated glucose concentrations to support patients who require immediate correction of low blood sugar or fluid replacement or electrolyte balance.

Glucosum is indicated for several clinical situations where rapid glucose supplementation or fluid replacement is required.

- Treatment of hypoglycemia when oral glucose is not feasible. - Support of parenteral nutrition regimens as a carbohydrate source. - Fluid and electrolyte replacement in patients with dehydration or postoperative fluid loss. - Management of electrolyte imbalances during intravenous therapy. - Adjunctive therapy during cardiac surgery or intensive care to maintain blood glucose levels. - Use in emergency settings to quickly restore circulating glucose during trauma or severe infection.

Glucosum may be associated with a range of adverse effects, most of which are related to its osmolarity, rapid glucose infusion, or electrolyte content.

Common: - Transient increase in blood glucose levels (hyperglycemia) that usually resolves after the infusion is completed. - Mild gastrointestinal discomfort such as nausea or occasional vomiting during or shortly after administration. - Local irritation or erythema at the intravenous insertion site, especially with rapid infusion rates. - Fluid overload, manifested as peripheral edema, in patients with pre‑existing cardiac or renal impairment.

Serious: - Severe hyperglycemia that may progress to osmotic diuresis, dehydration, and electrolyte loss if not monitored. - Electrolyte disturbances, including hyponatremia, hyperkalemia, or shifts in calcium and magnesium balance. - Acute hypotension caused by rapid infusion of a hypotonic solution, potentially leading to dizziness or syncope.

When using Glucosum, clinicians should observe specific precautions to minimize risks and ensure safe administration.

- Verify patient’s blood glucose level before initiating therapy to avoid excessive hyperglycemia. - Adjust infusion rate in patients with cardiac failure, renal insufficiency, or risk of fluid overload. - Monitor electrolytes (sodium, potassium, calcium) during and after the infusion. - Use aseptic technique and inspect the solution for particulate matter or discoloration before administration. - Document total glucose administered to prevent cumulative dosing errors. - Consider compatibility with other IV drugs; avoid mixing Glucosum with medications that may precipitate or cause incompatibility.

Glucosum can interact with certain intravenous agents or conditions; awareness of these interactions helps maintain therapeutic safety.

Avoid: - Avoid concurrent infusion of high‑dose insulin without glucose monitoring, as this may cause severe hypoglycemia. - Do not mix Glucosum with calcium‑containing solutions in the same line, which can precipitate.

Use with caution: - Use with caution when co‑administered with diuretics that affect electrolyte balance; monitor serum electrolytes closely. - Caution is advised when Glucosum is given alongside beta‑blockers, as they may mask signs of hypoglycemia. - When combined with hypertonic saline or other hyperosmolar solutions, adjust infusion rates to prevent fluid overload. - Use carefully in patients receiving total parenteral nutrition, ensuring total carbohydrate load does not exceed prescribed limits.